Gentamicin is a 4,6-disubstituted aminocyclitol antibiotic complex synthesised by some members of the actinomycete genus Micromonospora. In a search for the gentamicin biosynthetic gene cluster we identified, using a cosmid library approach, a region of the M. echinospora ATCC15835 chromosome that encodes homologues of aminoglycoside biosynthesis genes including gntB-a close homologue of the 2-deoxy-scyllo-inosose synthase gene (btrC) from butirosin-producing Bacillus circulans. Insertional inactivation was achieved by homologous recombination with an internal gntB fragment-containing suicide plasmid, delivered by conjugal transfer from Escherichia coli. gntB disruptants were gentamicin nonproducing mutants as assayed by an ELISA antibiotic detection system, proving the association of gntB (or a downstream region) with gentamicin biosynthesis. The function of some open reading frames within the cluster, predicted by nucleotide database homology searching, is discussed with regards to their potential roles in gentamicin biosynthesis. The discovery of this genetic region represents the first report of a gene cluster involved in the biosynthesis of a 4,6-disubstituted aminocyclitol antibiotic.
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The gentamicin antibiotic was discovered in 1963 and for forty years has been a useful agent for the treatment of severe bacterial infection1). In addition to its use as an antibacterial agent, the potential anti-viral properties of some gentamicin-conjugants have recently been demonstrated2), as has the ability of highly related structures to specifically bind catalytic RNAs3,4) and small ribozymes in vitro, suggesting possible future roles in the development of novel gentamicin-like drugs that specifically target RNA5).
Gentamicin is a water soluble aminocyclitol-containing aminoglycoside antibiotic complex, consisting predominantly of three major components: gentamicin C1, C1a and C2. The C1, C1a and C2 components (gentamicin Cs) are composed of a central di-aminogenous cyclitol (2-deoxystreptamine (2DOS)) 4,6-disubstituted with the auxiliary sugars garosamine and purpurosamine. Numerous biochemical studies have attempted to elucidate the biosynthetic route to the gentamicin Cs, and a branched pathway has been proposed based on precursor feeding studies of blocked mutants6-8). A complete mechanistic
pathway is yet to be described, however, and further work is required to clarify the proposed biosynthetic route to the gentamicin Cs. The gentamicin Cs act by binding to the decoding region of the aminoacyl-tRNA site of the ribosome, inhibiting translocation of the nascent peptide and decreasing translational accuracy5). Bacterial self-resistance to the gentamicin components is achieved by specific methylation of ribosomes, presumably catalysed by the GrmA gene product9). Prior to this report the grmA gene (and a short tandem region of unknown function) were the only reported genes believed to be associated with the gentamicin biosynthesis gene cluster.
Genetic studies have facilitated the study of diverse antibiotic biosynthesis pathways. Of particular relevance, Bacterial strains used in this study are listed in Table 1. liquid or on agar. Micromonospora strains were cultured on and cosmid used in this study are listed in Table 1 .
DNA Manipulations
Plasmid DNA was extracted from E. coli using the In Silica Analysis ORF analysis was conducted using the Artemis program.
The predicted amino acid sequences of all ORFs were analysed in BLASTP. Regions of secondary structure (dyad symmetries) within the cosmid clone were predicted using the Clone program where confidence was given to hairpin loops with energy of -25kcal mol-1 or less.
Creation of Disruption Cassette
Plasmid pSPRU27 was created as follows: a 525 bp internal fragment of gntB was amplified from pSPWAR001 DNA using primers gntBKOFPacI (5'-GGCCTTAATTAATGTTCGGCGCGGAACTGGTC-3') and gntBKORXbaI (5'-CTCTTCTAGAGCATGTAGCA GAGCAGCAGCAGCAT-3'). Pac I and Xba I recognition sites were incorporated into the PCR primers (underlined).
The PCR-amplified fragment was digested simultaneously Clarification of Disruption of gntB by pSPRU27
Chromosomal DNA was isolated from M. echinospora ATCC15835 exconjugant MegntB::pSPRU27a. Probe ORF4Pr was synthesised by the PCR using primers gntBPrf (5'-TGTTCGGCGCGGAACTGGTC-3') and gntB4Prr (5'-CGTACATCGTCTCGTCGTCGTA-3') and purified pSPWAR001 cosmid as template DNA, incorporating DIG dUTP as directed by the manufacturer (Roche). Southern hybridisation with probe gntBPr was performed at high stringency on agarose gel-separated chromosomal DNA that had been transferred to nitrocellulose filters after digestion with enzymes Bgl II and Nco I separately. The estimated sizes of the hybridising bands were compared to Fermentation of strain MegntB::pSPRU27a was carried out using Micromonospora seed18) and fermentation media19) and the methods described in WAGMAN et al. 19 ). Strain M. echinospora ATCC31119 (Daum's idiotrophic gentamicin non-producing mutant) was fermented in tandem as a negative control.
Isolation and Assay of Gentamicin Complex Components
The gentamicin complex components were obtained from whole fermentation broths as detailed in DRUM et al. 18 ).
Levels of the gentamicin C components were assayed using the Innofluor(R) GM assay system (Seradyn, Inc.) and a
TDxTM analyser (Bio-Stat Diagnostic Systems).
Results and Discussion
Cosmid pSPWAR001 contains a 38,146bp region of the M. echinospora ATCC15835 chromosome; analysis of predicted protein coding regions revealed the inserted DNA contained 28 ORFs, all of which appear complete ( Figure   1 ). The similarity of predicted primary amino acid sequences of each putative ORF to known sequences, and selected other details, are described in The cluster contained a complete 165 rRNA gene, and was also flanked by the 1366 by 3' region of a 23S rRNA gene. The self-resistance gene for the gentamicin complex is positioned in close proximity to the site of action of its gene product, this proximity has not been reported previously in other aminoglycoside producers.
In order to investigate whether genes in the cluster were involved in the biosynthesis of the gentamicin Cs, gntB (a close homologue of the 2-deoxy-scyllo-inosose synthase gene btrC from B. circulans) was insertionally inactivated with plasmid pSPRU27. The aac(3)IV gene was used as a selectable marker for homologous recombinants, and so traditional bioassay methods for the detection of gentamicin C production were not of use here (the aac(3)IV gene product inactivates the gentamicin Cs by acetylation). In preference we adopted the Innofluor(R) ELISA system as it detects the gentamicin C components, and the respective biologically inactive N-acetyl derivatives of each generated by the action of the aac(3)IV gene product (manufacturer's personal communication). In results to be fully reported elsewhere, the Innofluor(R) system detected the N-acetyl In addition to grmA, the pSPWAR001 insert appears to encode at least two additional resistance genes. The existence of a second resistance methyltransferase gene (grmO) is supported by previous workers27) but GntN is the first presumed aminoglycoside export protein known to be physically linked with a 2DOS containing aminoglycoside biosynthetic cluster. The gntI gene may play a resistance, regulatory or biosynthesis role. The predicted GntI protein shares significant similarity with a number of aminoglycoside-O-phosphoryltransferases of the APH(3')-Vc family-enzymes that inactivate certain aminoglycosides hydroxyl moiety of the acceptor aminoglycoside. It is unlikely that the gntI gene acts as major resistance determinant to the gentamicin Cs as each lack the 3' hydroxyl group which acts as an acceptor for phosphoryltransfer from ATP. GntI may have a regulatory role in gentamicin biosynthesis as there is a known phylogenetic link between APH enzymes and protein kinases28), and APH(3')-III enzymes (that are closely related to the APH(3')-V family) can phosphorylate some protein and peptide substrates. GntI contains the common site motif (Lys44, Glu60, Asp195, Asp208) that resembles the active site residues found in the Ser/Thr/Tyr protein kinase family29). Tyrosine kinases have previously been implicated in the regulation of streptomycin biosynthesis in S. griseus30). Involvement in a biosynthetic step is also feasible, similar to that proposed for the product of the fms8 in fortimicin biosynthesis in M. olivasterospora. DAIRI et al.26) showed fms8 was able to complement mutants deficient in the double dehydroxylation step of FTM-A biosynthesis (FTM-KK1 to FTM-AP). The biosynthetic step could, however, also be carried out by the M. chalcea and S. fradiae APH(3')-V phosphotransferases. This led to the conclusion that the double dehydroxylation step is preceded by a 3' phosphorylation step, as is catalysed by typical APH(3')-V enzymes. Two very similar steps have been proposed in gentamicin biosynthesis and hence the protein could effect the conversion of JI20A to gentamicin C1a, and JI20B to gentamicin C2. The nucleotide sequence of fms8 has not been submitted to the NCBI database, so comparison of the GntI and Fms8 sequences has not been possible.
